Latest Vecuronium Stories
KENILWORTH, N.J., Sept.
KENILWORTH, N.J., July 29 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced that the European Commission (EC) has approved BRIDION(R) (sugammadex) injection, the first and only selective relaxant binding agent (SRBA) and the first major pharmaceutical advance in the field of anesthesia in two decades.
KENILWORTH, N.J., March 11 /PRNewswire-FirstCall/ -- Schering-Plough today announced that the U.S. Food and Drug Administration (FDA) Advisory Committee on Anesthetics and Life Support has recommended sugammadex for approval.
- A gift; a largess; a gratuity; a present; a dole.